Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $3,226 - $3,894
12 Added 1.65%
738 $209,000
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $68,016 - $76,730
-266 Reduced 26.81%
726 $209,000
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $132,064 - $163,961
-604 Reduced 37.84%
992 $266,000
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $84,850 - $100,334
396 Added 33.0%
1,596 $354,000
Q1 2023

May 05, 2023

BUY
$225.79 - $275.2 $46,061 - $56,140
204 Added 20.48%
1,200 $290,000
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $37,789 - $48,016
-165 Reduced 14.21%
996 $261,000
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $68,909 - $77,717
-307 Reduced 20.91%
1,161 $262,000
Q2 2022

Jul 29, 2022

BUY
$230.71 - $256.74 $63,906 - $71,116
277 Added 23.26%
1,468 $357,000
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $39,468 - $43,662
-180 Reduced 13.13%
1,191 $288,000
Q4 2021

Feb 04, 2022

SELL
$198.88 - $227.6 $1,193 - $1,365
-6 Reduced 0.44%
1,371 $308,000
Q3 2021

Oct 25, 2021

SELL
$212.27 - $248.7 $16,557 - $19,398
-78 Reduced 5.36%
1,377 $293,000
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $22,423 - $24,877
96 Added 7.06%
1,455 $355,000
Q1 2021

May 05, 2021

SELL
$221.91 - $258.6 $41,940 - $48,875
-189 Reduced 12.21%
1,359 $338,000
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $28,562 - $34,012
-132 Reduced 7.86%
1,548 $356,000
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $55,612 - $61,845
237 Added 16.42%
1,680 $427,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $65,277 - $80,104
-330 Reduced 18.61%
1,443 $340,000
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $2,915 - $3,867
16 Added 0.91%
1,773 $360,000
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $18,731 - $24,076
99 Added 5.97%
1,757 $424,000
Q3 2019

Nov 13, 2019

BUY
$174.11 - $208.62 $172,543 - $206,742
991 Added 148.58%
1,658 $321,000
Q2 2019

Jul 19, 2019

SELL
$166.7 - $195.41 $30,506 - $35,760
-183 Reduced 21.53%
667 $123,000
Q1 2019

May 01, 2019

SELL
$180.87 - $203.88 $53,718 - $60,552
-297 Reduced 25.89%
850 $161,000
Q4 2018

Feb 05, 2019

SELL
$178.4 - $208.25 $713 - $833
-4 Reduced 0.35%
1,147 $223,000
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $94,683 - $106,742
511 Added 79.84%
1,151 $238,000
Q2 2018

Jul 31, 2018

SELL
$166.05 - $186.51 $53,302 - $59,869
-321 Reduced 33.4%
640 $118,000
Q1 2018

Apr 05, 2018

BUY
$169.43 - $198.0 $162,822 - $190,278
961 New
961 $164,000
Q3 2017

Nov 09, 2017

SELL
$167.29 - $191.0 $197,569 - $225,571
-1,181 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
1,181
1,181 $203,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Destination Wealth Management Portfolio

Follow Destination Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.